RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 76 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $499,000 | +67.4% | 55,579 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $298,000 | +26.8% | 55,579 | +9.0% | 0.00% | 0.0% |
| Q1 2016 | $235,000 | -15.5% | 51,010 | -4.7% | 0.00% | 0.0% |
| Q4 2015 | $278,000 | -26.3% | 53,510 | -14.0% | 0.00% | -50.0% |
| Q3 2015 | $377,000 | -61.6% | 62,238 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $983,000 | +90.9% | 62,238 | +31.3% | 0.00% | +100.0% |
| Q1 2015 | $515,000 | +2.4% | 47,404 | -0.8% | 0.00% | 0.0% |
| Q4 2014 | $503,000 | +8.4% | 47,795 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $464,000 | -16.4% | 48,374 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $555,000 | +20.9% | 48,050 | +4.6% | 0.00% | 0.0% |
| Q1 2014 | $459,000 | -23.6% | 45,924 | -0.5% | 0.00% | -33.3% |
| Q4 2013 | $601,000 | -15.4% | 46,132 | -2.9% | 0.00% | 0.0% |
| Q3 2013 | $710,000 | +83.0% | 47,529 | +14.6% | 0.00% | +50.0% |
| Q2 2013 | $388,000 | – | 41,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|